Advances in the use of EGFR TKIs in the Treatment of NSCLC

Paola Ulivi, Yusuke Okuma, Santiago Viteri

Frontiers Media SA

Lung cancer is the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer...

Health Oncology Thoracic Oncology

Keywords: EGFR mutation,­TKI,­tyrosine kinase inhibitor,­lung cancer,­NSCLC,­thoracic oncology,­combination therapy,­resistance mechanisms

Novel Biomarkers for Potential Clinical Applications in Lung Cancer

Hongda Liu, Donghong Zhang, Ping Zhan, Qingqing Zhu, Miao Liu

Frontiers Media SA

More and more medical centers are now combining high-resolution CT scans well with deep learning...

Health Oncology Thoracic Oncology

Keywords: biomarker,­diagnosis,­targeted therapy,­lung cancer,­prognosis

Recent Advances in Surgical Management of NSCLC

Marcello Migliore, Domenico Galetta, Masayuki Chida

Frontiers Media SA

Lung cancer remains a leading cause of cancer-related deaths worldwide, and non-small cell lung...

Health Oncology Thoracic Oncology

Keywords: Surgery,­wedge resection,­NSCLC,­lung cancer,­surgical techniques

Case Reports in Thoracic Oncology: 2022

Caroline Hayhurst, Kohei Fujita, Yaron Perry

Frontiers Media SA

This Research Topic aims to collect all the Case Reports submitted to the Thoracic Oncology...

Health Oncology Thoracic Oncology

Keywords: thoracic,­oncology,­case,­Report,­#CollectionSeries

Real-World Data and Real-World Evidence in Lung Cancer

Valerio Gristina, Chukwuka Eze

Frontiers Media SA

Lung cancer is still one of the most common malignancies with a high global mortality rate with...

Health Oncology Thoracic Oncology

Keywords: Real world data,­Real world evidence,­lung cancer,­NSCLC,­ICI,­TKI

Primary and Acquired Resistance in Lung Cancer

Rossella Bruno, Michele Simbolo, Iacopo Petrini

Frontiers Media SA

Lung cancer is one of the leading causes of cancer-related death worldwide with a prevalence of...

Health Oncology Thoracic Oncology

Keywords: lung cancer,­kinase inhibitors,­primary resistance,­acquired resistance,­biomarkers,­Molecular tests,­heterogeneity,­Co-occurring mutations

Optimizing Outcomes and Addressing Adversities of Immunotherapy in Lung Cancer

Jun Zhang, Oscar Arrieta, Jarushka Naidoo

Frontiers Media SA

Health Oncology Thoracic Oncology

Keywords: lung cancer,­Immunotherapy,­immune-related adverse effects,­irAEs,­Adversities,­outcomes

Neoadjuvant therapy in non-small cell lung cancer: Clinical, pathological and translational research

Min Li, Roy S. Herbst, Fan Yang

Frontiers Media SA

Health Oncology Thoracic Oncology

Keywords: lung cancer,­Neoadjuvant Therapy,­Surgery,­Pathological features,­Molecular features,­biomarkers

Influence of Potential Diagnostic Biomarkers in Lung Cancer

Paul Takam Kamga, Jarushka Naidoo

Frontiers Media SA

Lung cancer remains as one of the most common malignancies with a high global mortality rate. The...

Health Oncology Thoracic Oncology

Keywords: lung cancer,­Diagnostic Markers,­biomarkers,­Non-small cell lung cancer,­prognosis